Iopamiro

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a solution for injection for intravenous use. It enhances radiographic visibility of vascular and tissue structures during diagnostic imaging procedures, aiding clinicians in evaluating patients undergoing CT, angiography, urography, or myelography.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with consistent quality and regulatory compliance, and reliable delivery timelines across multiple regions, ensuring availability for urgent imaging needs.

Iopamiro is an iodinated contrast agent used to improve visualization of vascular and tissue structures in diagnostic imaging.

- CT imaging: provides enhanced contrast to delineate anatomical details, supporting accurate diagnosis. - Angiography: highlights blood vessels to assess patency, stenosis, or aneurysms. - Urography: improves delineation of the urinary tract for detection of obstruction or stones. - Myelography: enhances spinal canal imaging to identify disc herniation or spinal stenosis.

Iopamiro may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate feeling of sickness during or after injection. - Warmth or flushing: transient sensation of heat or reddening at the injection site. - Metallic taste: brief taste disturbance reported by some patients. - Headache: mild headache that usually resolves without intervention.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Renal impairment: acute kidney injury, particularly in patients with pre‑existing renal disease. - Contrast‑induced nephropathy: significant rise in serum creatinine within 48‑72 hours after administration.

Prior to using Iopamiro, clinicians should consider several safety measures. - Renal function assessment: evaluate baseline kidney function before administration. - Hydration status: ensure adequate patient hydration to reduce nephrotoxicity risk. - Allergy history: screen for prior reactions to iodinated contrast agents. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep vials below 25 °C, protect from light and moisture.

Iopamiro can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent use of high‑dose nephrotoxic drugs (e.g., aminoglycosides): may exacerbate renal injury. - Iodine‑containing medications (e.g., amiodarone, thyroid hormones): increase total iodine load.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid balance and renal clearance. - Metformin: consider temporary discontinuation in patients with impaired renal function. - Beta‑blockers: may mask contrast‑induced hypotension.